drugset / Trial / NCT06230146

Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.

NCT06230146

Phase 1/2 Unknown 45 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

Keloids are macroscopic cutaneous scarring that result from disturbance of wound healing, that occurs on predisposed individuals . Keloid shows a kind of over-healing, producing over abundant wound matrix responsible for raised, inflexible red scar tissue, that causes pain and itching .

Timeline

Start
2024-05-01
Primary completion
2026-01-01
Completion
2026-05-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 2.5 iu Other
Subject Insulin Protein / enzyme biologic 0.1 ml Other
Subject Triamcinolone Acetonide Other / unclassified 40 mg Other

Indications